Impax Labs Enters Commercialization Deal with Perrigo
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.